ADIPOQ and non-alcoholic fatty liver: Although serum adiponectin levels were demonstrated to be similar in non-alcoholic fatty liver (NAFL) patients and controls based on liver histology, hypoadiponectinemia may exert an essential role in the progression from NAFL to non-alcoholic steatohepatitis (NASH) [17].